This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked GSTA2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-GSTA2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~25.7 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Duodenum (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Acetylated | |
| Caveat | Band size unreported | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A04171 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of various cells, (catalog A04171) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A04171; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
GSTA2's predicted monomer is 25.7 kDa; dimerization could affect migration under native conditions, but no empirical Western blot band size is supplied.
| Single band near 25.7 kDa | Consistent with the predicted GSTA2 monomer; confirm identity with antibody controls |
| Band near twice the monomer size under native conditions | Could reflect a retained GSTA2-containing dimer |
| Monomer band plus a higher band under native conditions | Could reflect both free GSTA2 and retained dimers |
| Little or no band in a membrane-only fraction | Consistent with GSTA2's cytoplasmic location |
| Predicted GSTA2 monomer mass | Provides a 25.7 kDa reference for the subunit |
| GSTA2 homodimer | Could appear near twice the monomer size if association survives sample preparation |
| GSTA1–GSTA2 heterodimer | Could produce a higher apparent size if the complex remains associated; its mass is not supplied |
| Dissociation of GSTA2-containing dimers | Returns associated subunits toward their individual apparent sizes under denaturing conditions |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Cytoplasmic GSTA2 may be lost during fractionation | Check the soluble cytoplasmic fraction and a loading control |
| Band higher than expected | A GSTA2-containing dimer may remain associated | Compare native and fully denatured samples; confirm band identity |
| Band lower than expected | Possible sample degradation; no cleavage feature is listed | Prepare fresh lysate with protease inhibitors and verify antibody specificity |
| Multiple bands | Possible retained dimers alongside monomers or antibody cross-reactivity | Compare denaturation conditions and use an independent antibody or depletion control |
| Weak or no signal | Insufficient cytoplasmic protein or poor transfer | Check protein loading, the soluble fraction, and transfer efficiency |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Duodenum | endocrine cells | High | Protein (IHC) | HPA → |
| Liver | hepatocytes | High | Protein (IHC) | HPA → |
| Testis | Leydig cells | High | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Fallopian tube | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Appendix | endocrine cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for GSTA2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A04171 is an anti-GSTA2 antibody listed for Western blot with reported human, mouse, and rat reactivity. Its WB image is described as using extracts of various cells; the supplied evidence does not identify the cells or blot conditions.
Which to pick: A04171 is the only listed option for GSTA2 and has a WB image. Check that its reported reactivity matches your species; the supplied image description does not specify the tested cells.